CBS2020 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

HOME
ABOUT CBS
- About CBS
  
  Overview Welcome Message Associations and Affiliations Contact US
- Previous CBS
  
  CBS 2019 CBS 2017 CBS 2016 CBS 2015
FACULTY
- Faculty
  
  General Chairman Congress Co-Chairman Executive Chairman General Secretary International Faculty Faculty FACULTY-HONGKONG/MACAU/TAIWAN
PROGRAM
- Phase I
- Phase II
- Phase III
- Phase IV
- Phase V
- Phase VI
- Phase VII
- Phase VIII
- Phase Ⅸ
- Phase Ⅹ
EDUCATION CENTER
- Scientific Library
  
  Acute Coronary Syndrom ASCVD Prevention Bifurcation Stenting Cardio-Oncology Congestive Heart Failure DAPT Duration Drug Coated Balloon Fractional Flow Reserve IVUS Guidance
  
  Optical Coherence Tomography Pulmonary Hypertension Rotational Atherectomy Shear Stress Stenting Left Main Transcatheter Aortic Valve Replacement Percutaneous LAA Occlusion Mitral/Tricuspid Valvular Disease Other Relevant Articles
- News
  
  Hot Points News
- Cases Videos
  
  CTO Pacemaker TAVI LMCA Aorta
- E-Learning
  
  Interviews Slides Courseware
- Industry Insights
  
  Top 10 Research Paper Pre-Reading Discussions
LIVE

中 Sign In

Education Center >> Scientific Library >>Percutaneous LAA Occlusion

Clinical Trial

2021 Apr 6;143(14):1377-1390.

JOURNAL：

Article Link

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial
DL Packer, JP Piccini, CABANA Investigators et al.

KEYWORDS
AF; ablation versus drug therapy; outcome; RCT

http://www.cbsmd.cn Contact us by cbs@cbsmd.cn